Boc-4-nitro-L-phenylalanine

We are Boc-4-nitro-L-phenylalanine CAS:33305-77-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Boc-4-nitro-L-phenylalanine
CAS.NO: 33305-77-0
Molecular Formula: C14H18N2O6
Molecular Weight: 310.30300

Synonyms:
N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-4-nitro-L-phenylalanine
Boc-4-Nitro-L-Phenylalanine
BOC-PHE(P-NO2)-OH
Boc-L-4-NO2-Phe-OH
BOC-L-4-NITROPHE
Boc-D-phe(4-NO2)-OH
BOC-(P-NO2)PHE-OH
N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-4-nitrophenylalanine
Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-nitro-
BOC-P-NITRO-PHE-OH
N-(t-butyloxycarbonyl)-4-nitro-D,L-phenylalanine
L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-nitro-
Boc-Phe(4-NO2)-OH
N-tert-butoxycarbonyl-p-nitro-L-phenylalanine
BOC-PNO2-L-PHE-OH
BOC-4-NITRO-PHE-OH
n-(tert-butoxycarbonyl)-4-nitrophenylalanine
BOC-L-PHE(4-NO2)
(S)-2-t-butyloxycarbonylamino-3-(4-nitrophenyl)propionic acid

Physical and Chemical Properties:
Density: 1.29 g / cm3
Boiling point: 509.3ºC at 760 mmHg
Melting point: 107ºC
Flash point: 261.8ºC
Refractive index: 1.553

Specification:
Appearance: White powder
Purity:≥99%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:-20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

Related News: There are also new directives that relate to US citizens.Ethyl 3-chloro-4-fluorobenzoate The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.6-Iodo-1H-indazole According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.4-FLUORO-2-NITROANILINA CAS:364-71-6 According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.